Top ▲
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | - | 1531 | 17q21.2 | TOP2A | DNA topoisomerase II alpha | |
Mouse | - | 1528 | 11 62.91 cM | Top2a | topoisomerase (DNA) II alpha | |
Rat | - | 1526 | 10q31 | Top2a | DNA topoisomerase II alpha |
Previous and Unofficial Names |
DNA topoisomerase 2-alpha | topoisomerase (DNA) II alpha | topoisomerase (DNA) II alpha 170kDa |
Database Links | |
Alphafold | P11388 (Hs), Q01320 (Mm), P41516 (Rn) |
BRENDA | 5.99.1.2 |
CATH/Gene3D | 3.30.565.10, 3.30.1360.40, 3.30.230.10, 1.10.268.10, 3.40.50.670, 3.90.199.10 |
ChEMBL Target | CHEMBL1806 (Hs), CHEMBL3586 (Mm), CHEMBL3400 (Rn) |
DrugBank Target | P11388 (Hs) |
Ensembl Gene | ENSG00000131747 (Hs), ENSMUSG00000020914 (Mm), ENSRNOG00000053047 (Rn) |
Entrez Gene | 7153 (Hs), 21973 (Mm), 360243 (Rn) |
Human Protein Atlas | ENSG00000131747 (Hs) |
KEGG Enzyme | 5.99.1.2 |
KEGG Gene | hsa:7153 (Hs), mmu:21973 (Mm), rno:360243 (Rn) |
OMIM | 126430 (Hs) |
Orphanet | ORPHA353516 (Hs) |
Pharos | P11388 (Hs) |
RefSeq Nucleotide | NM_001067 (Hs), NM_011623 (Mm), NM_022183 (Rn) |
RefSeq Protein | NP_001058 (Hs), NP_035753 (Mm), NP_071519 (Rn) |
UniProtKB | P11388 (Hs), Q01320 (Mm), P41516 (Rn) |
Wikipedia | TOP2A (Hs) |
Enzyme Reaction | ||||
|
Download all structure-activity data for this target as a CSV file
Inhibitors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
View species-specific inhibitor tables |
Immuno Process Associations | ||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||
|
1. Albino D, Scaruffi P, Moretti S, Coco S, Truini M, Di Cristofano C, Cavazzana A, Stigliani S, Bonassi S, Tonini GP. (2008) Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory. Cancer, 113 (6): 1412-22. [PMID:18671248]
2. Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK. (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry, 28 (20): 8154-60. [PMID:2557897]
3. Hasinoff BB, Liang H, Wu X, Guziec LJ, Guziec Jr FS, Marshall K, Yalowich JC. (2008) The structure-based design, synthesis and biological evaluation of DNA-binding bisintercalating bisanthrapyrazole anticancer compounds. Bioorg Med Chem, 16 (7): 3959-68. [PMID:18258442]
4. Suzuki K, Yahara S, Maehata K, Uyeda M. (2001) Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba. J Nat Prod, 64 (2): 204-7. [PMID:11430001]
DNA topoisomerases: DNA topoisomerase II alpha. Last modified on 18/08/2017. Accessed on 22/01/2025. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2637.